Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
Lipid changes during basal insulin peglispro, insulin glargine, or NPH treatment in six IMAGINE trialsGinsberg, Henry ; Cariou, Bertrand ; Orchard, Trevor ; Chen, Lei ; Luo, Junxiang ; Bastyr III, Edward J. ; Bue-Valleskey, Juliana ; Chang, Annette M. ; Ivanyi, Tibor ; Jacober, Scott J. ; Hoogwerf, Byron J.Diabetes, obesity & metabolism, 2016-11, Vol.18 (11), p.1089-1092Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Peripherally delivered hepatopreferential insulin analog insulin‐406 mimics the hypoglycaemia‐sparing effect of portal vein human insulin infusion in dogsGregory, Justin M. ; Kraft, Guillaume ; Scott, Melanie F. ; Neal, Doss W. ; Farmer, Ben ; Smith, Marta S. ; Hastings, Jon R. ; Madsen, Peter ; Kjeldsen, Thomas B. ; Hostrup, Susanne ; Brand, Christian L. ; Fledelius, Christian ; Nishimura, Erica ; Cherrington, Alan D.Diabetes, obesity & metabolism, 2019-10, Vol.21 (10), p.2294-2304Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
U-100, pH-Neutral formulation of VIAject®: faster onset of action than insulin lispro in patients with type 1 diabetesHeinemann, L. ; Nosek, L. ; Flacke, F. ; Albus, K. ; Krasner, A. ; Pichotta, P. ; Heise, T. ; Steiner, S.Diabetes, obesity & metabolism, 2012-03, Vol.14 (3), p.222-227Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
Glucose transporter expression on the plasma membrane of resting and activated white blood cellsMaratou, E. ; Dimitriadis, G. ; Kollias, A. ; Boutati, E. ; Lambadiari, V. ; Mitrou, P. ; Raptis, S. A.European journal of clinical investigation, 2007-04, Vol.37 (4), p.282-290 [Periódico revisado por pares]Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Insulin analogues display IGF-I-like mitogenic and anti-apoptotic activities in cultured cancer cellsWeinstein, Doron ; Simon, Meital ; Yehezkel, Einat ; Laron, Zvi ; Werner, HaimDiabetes/metabolism research and reviews, 2009-01, Vol.25 (1), p.41-49 [Periódico revisado por pares]Chichester, UK: John Wiley & Sons, LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Weight loss in patients with type 2 diabetes receiving once‐weekly dulaglutide plus insulin lispro or insulin glargine plus insulin lispro: A post‐hoc analysis of the AWARD‐4 study across baseline body mass index subgroupsFuechtenbusch, Martin ; Aberle, Jens ; Heitmann, Elke ; Nicolay, Claudia ; Jung, HeikeDiabetes, obesity & metabolism, 2019-06, Vol.21 (6), p.1340-1348Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
Effectiveness of Regular Versus Glargine Insulin in Stable Critical Care Patients Receiving Parenteral Nutrition: A Randomized Controlled TrialOghazian, Mohammad Bagher ; Javadi, Mohammad Reza ; Radfar, Mania ; Torkamandi, Hassan ; Sadeghi, Mostafa ; Hayatshahi, Alireza ; Gholami, KheirollahPharmacotherapy, 2015-02, Vol.35 (2), p.148-157 [Periódico revisado por pares]United States: Blackwell Publishing LtdTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Metabolic control and risk of hypoglycaemia during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysisPontiroli, A. E. ; Miele, L. ; Morabito, A.Diabetes, obesity & metabolism, 2012-05, Vol.14 (5), p.433-446Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Reduced peripheral activity leading to hepato-preferential action of basal insulin peglispro compared with insulin glargine in patients with type 1 diabetesMudaliar, S. ; Henry, R. R. ; Ciaraldi, T. P. ; Armstrong, D. A. ; Burke, P. M. ; Pettus, J. H. ; Garhyan, P. ; Choi, S. L. ; Knadler, M. P. ; Lam, E. C. Q. ; Prince, M. J. ; Bose, N. ; Porksen, N. K. ; Sinha, V. P. ; Linnebjerg, H. ; Jacober, S. J.Diabetes, obesity & metabolism, 2016-10, Vol.18 (S2), p.17-24Oxford, UK: Blackwell Publishing LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
Adding insulin glargine vs. NPH insulin to metformin results in a more efficient postprandial β-cell protection in individuals with type 2 diabetesForst, T ; Larbig, M ; Hohberg, C ; Forst, S ; Diessel, S ; Borchert, M ; Roth, W ; Pfützner, ADiabetes, obesity & metabolism, 2010-05, Vol.12 (5), p.437-441Oxford, UK: Oxford, UK : Blackwell Publishing LtdTexto completo disponível |